| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/07/2010 | EP2170866A1 Phthalazine compounds, compositions and methods of use |
| 04/07/2010 | EP2170861A2 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
| 04/07/2010 | EP2170857A2 3',4',5-trimethoxy flavone derivatives as stimulant of mucus secretion, method of the same, and pharmaceutical composition comprising the same |
| 04/07/2010 | EP2170843A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions |
| 04/07/2010 | EP2170831A1 Benzazepine derivatives useful as vasopressin antagonists |
| 04/07/2010 | EP2170329A2 Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin |
| 04/07/2010 | EP2170328A2 Crystalline polymorph of exemestane |
| 04/07/2010 | EP1673368B1 Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes |
| 04/07/2010 | EP1551829B1 Novel compounds with antibacterial activity |
| 04/07/2010 | EP1527050B1 Quinoline derivatives and their use as mycobacterial inhibitors |
| 04/07/2010 | CN101691360A Preparation method of carbamyl benzotriazole |
| 04/07/2010 | CN101691353A N-Boc-3,5-(E)-diarylidene-4-piperidone and application thereof in preparation of anti-tumor drugs |
| 04/06/2010 | US7692028 for treating neurological disorders such as epilepsy, neuropathic pain, bipolar disorder or migraine; 2-(2-oxo-4-propyl-1-pyrrolidinyl)butanamide; neuroprotective agent |
| 04/06/2010 | US7692009 Reference standard for characterization of rosuvastatin |
| 04/06/2010 | US7691883 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis |
| 04/06/2010 | US7691881 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide derivatives having 5-HT4 receptor agonistic activity |
| 04/06/2010 | US7691854 Diethyl 2-amino-4-(4-cyanophenyl)-6-methyl-1-(3-methylphenyl)-1,4-dihydro-3,5-pyridine-dicarboxylate; chronic obstructive pulmonary disease, acute coronary syndrome, acute myocardial infarction or development of heart failure |
| 04/06/2010 | US7691853 Pyrazole compounds useful as protein kinase inhibitors |
| 04/06/2010 | US7691843 Inhibitors of UPD-3-O (R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase, an enzyme present in gram negative bacteria; azetidine, pyrrolidine, or 3-pyrroline 2-carboxylic acid hydroxyamides; 1-(3,4-dimethoxy-5-propylbenzoyl)pyrrolidine-2R-carboxylic acid hydroxyamide for example |
| 04/06/2010 | US7691837 e.g. 1-{[1,5-bis(4-cholorophenyl)-2-methylpyrrol-3-yl]methyl}-4-(4-fluoro-phenyl)piperazine; Mycobacterium tuberculosis, drug resistant Mycobacterium tuberculosis, Mycobacterium avium-intracellulare complex, Mycobacterium fortuitum or Mycobacterium kansasi |
| 04/06/2010 | US7691785 Pyridine-3-ketone compound; plant growth controllers |
| 04/06/2010 | CA2496712C New process for synthesizing derivatives of 1,3,4,5-tetrahydro-2h-3-benzazepin-2-one and its application to the synthesis of ivabradine and its pharmaceutically acceptable acid addition salts |
| 04/06/2010 | CA2449899C Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor |
| 04/06/2010 | CA2397636C Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/06/2010 | CA2319807C Novel antifungal compound and process for producing the same |
| 04/01/2010 | WO2010037129A1 Quinazolinone, quinolone and related analogs as sirtuin modulators |
| 04/01/2010 | WO2010037066A2 Dosage units of 3-(6-(1-(2,2-difluorobenzo [d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 04/01/2010 | WO2010036631A2 Compounds which selectively modulate the cb2 receptor |
| 04/01/2010 | WO2010036630A2 Compounds which selectively modulate the cb2 receptor |
| 04/01/2010 | WO2010036613A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 04/01/2010 | WO2010035766A1 Method for producing triazole derivative |
| 04/01/2010 | WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient |
| 04/01/2010 | WO2010035727A1 Novel pyrrolinone derivative and medicinal composition containing same |
| 04/01/2010 | WO2010034797A1 1h-benzimidazole-5-carboxamides as anti-inflammatory agents |
| 04/01/2010 | WO2010034796A1 1h-benz imidazole-5-carboxamides as anti-inflammatory agents |
| 04/01/2010 | WO2010034671A1 Pyrine or pyrazine derivatives for treating hcv |
| 04/01/2010 | WO2010017545A3 Triazole compounds that modulate hsp90 activity |
| 04/01/2010 | US20100081686 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter |
| 04/01/2010 | US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 04/01/2010 | US20100081658 Heterocyclic antiviral compounds |
| 04/01/2010 | US20100081203 Fluorescent isotope tags and their method of use |
| 04/01/2010 | CA2738809A1 Quinazolinone, quinolone and related analogs as sirtuin modulators |
| 04/01/2010 | CA2738083A1 1h-benzimidazole-5-carboxamides as anti-inflammatory agents |
| 04/01/2010 | CA2737694A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 04/01/2010 | CA2737645A1 Compounds which selectively modulate the cb2 receptor |
| 04/01/2010 | CA2737639A1 Compounds which selectively modulate the cb2 receptor |
| 04/01/2010 | CA2737384A1 1h-benzimidazole-5-carboxamides as anti-inflammatory agents |
| 04/01/2010 | CA2736545A1 Dosage units of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 04/01/2010 | CA2736472A1 Pyrine or pyrazine derivatives for treating hcv |
| 03/31/2010 | EP2168962A2 Phenylacetamides and their use as glucokinase modulators |
| 03/31/2010 | EP2168958A1 Isoindole-Imide Compounds, Compositions And Uses Thereof |
| 03/31/2010 | EP2168951A1 Azolylmethylenehydrazine derivative and use thereof |
| 03/31/2010 | EP2168947A1 Novel compound having secretase inhibitory activity |
| 03/31/2010 | EP2168576A2 New utilities of tricyclic compounds |
| 03/31/2010 | EP2167494A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives |
| 03/31/2010 | EP2167487A1 Pyrrole derivatives as p2y12 antagonists |
| 03/31/2010 | EP2167485A2 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| 03/31/2010 | EP2167484A2 Condensed anthranilamide insecticides |
| 03/31/2010 | EP2167472A2 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 03/31/2010 | EP2167466A1 N-phenyl hydrazides as modulators of the ghrelin receptor |
| 03/31/2010 | EP2167083A2 Novel 1- heteroaryl-3-azabicycloý3.1.0¨hexanes, methods for their preparation and their use as medicaments |
| 03/31/2010 | EP2166854A1 Triazole derivatives for treating alzheimer's disease and related conditions |
| 03/31/2010 | EP2166850A1 New heteocyclic h3 antagonists |
| 03/31/2010 | EP2166849A1 Substituted pyrazole compounds |
| 03/31/2010 | EP1904465B1 Method of synthesis of imidazole-amino acid derivatives and related compounds |
| 03/31/2010 | EP1546107B1 Cox-2 inhibiting pyridine derivatives |
| 03/31/2010 | EP1252139B1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides |
| 03/31/2010 | CN101687913A kallikrein 7 modulators |
| 03/31/2010 | CN101687860A Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain |
| 03/31/2010 | CN101687859A Process for the preparation of alfuzosin and salts thereof |
| 03/31/2010 | CN101687858A 1, 3-dihydroimidazole- 2 -thione derivatives as inhibitors of dopamine-beta-hydroxylase |
| 03/31/2010 | CN101687853A Pyrimidine derivatives and compositions as C-KIT and PDGFR kinase inhibitors |
| 03/31/2010 | CN101687850A Substituted pyrimidines as adenosine receptor antagonists |
| 03/31/2010 | CN101687844A Imidazole derivatives as CCR2 receptor antagonists |
| 03/31/2010 | CN101687843A Substituted aromatic heterocyclic compounds as fungicides |
| 03/31/2010 | CN101687842A modulators of cftr |
| 03/31/2010 | CN101687841A Benzimidazole derivatives |
| 03/31/2010 | CN101687817A Tri-amino-pyrimidine cyclobutenedione derivatives used as phosphatase cdc25 inhibitors |
| 03/31/2010 | CN101687816A Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase |
| 03/31/2010 | CN101687812A 2 -imidazolines having a good affinity to the trace amine associated receptors (TAAR) |
| 03/31/2010 | CN101687807A 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 03/31/2010 | CN101687805A Benzazepine derivatives useful as vasopressin antagonists |
| 03/31/2010 | CN101687786A Hydroxylamine compounds and methods of their use |
| 03/31/2010 | CN101686969A crystalline polymorph of exemestane |
| 03/31/2010 | CN101686968A crystalline polymorph of 7-ethyl-10-hydroxycamptothecin |
| 03/31/2010 | CN101684115A 4-(5-((2-(4-morpholinyl-6-phenylamino group-1,3,5-triazine-2-base) hydrazono) methyl) furan-2-base) benzoic acid, preparing method and application thereof |
| 03/31/2010 | CN101684097A Phenylpyrimidine amines as ige inhibitors |
| 03/31/2010 | CN101684095A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 03/31/2010 | CN101684091A cannabinoid receptor ligands |
| 03/31/2010 | CN101684089A bicycloester derivative |
| 03/30/2010 | US7687643 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction |
| 03/30/2010 | US7687640 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde; inhibits production of A beta 40 and A beta 42 from amyloid precursor protein ; Alzheimer's disease and Down syndrome |
| 03/30/2010 | US7687639 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide |
| 03/30/2010 | US7687631 Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonate |
| 03/30/2010 | US7687535 Substituted 3-sulfur indoles |
| 03/30/2010 | US7687532 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of I.A. rheumatoid arthritis |
| 03/30/2010 | US7687525 e.g. N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; anticarcinogenic, antitumor agents; hematologic malignancy and a solid carcinoma; autoimmune disease, skin disorders; |
| 03/30/2010 | US7687514 Benzimidazole derivatives |
| 03/30/2010 | US7687510 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 03/30/2010 | US7687503 2-(methylamino)-2-oxoethyl 4-{5-[3-(trifluoromethyl)-phenyl]-2-pyridyl}-1-piperazinecarboxylate, for example; enzyme inhibitors of fatty acid amide hydrolases; treatment of pain, eating disorders, neurological and psychiatric pathologies, among other disorders |